New Chairman of the Board for Melanoma Institute Australia
1 March 2017
We are delighted to announce the appointment of Mr Grant King as Chairman of the Board of Melanoma Institute Australia.
Mr King’s appointment follows the retirement of Reg Richardson AM who led the MIA Board for the last 10 years.
“Under Mr Richardson’s leadership the Institute has firmly cemented its reputation as a global luminary in the fight against melanoma, and we are now leading international research which is resulting in innovative new treatments and prolonged life expectancies for even advanced melanoma patients,” said the CEO of MIA Carole Renouf.
“Mr King’s experience in strategy and business development, as well as his interest in community and philanthropic causes, will be critical in galvanising ongoing medical, scientific and government support for melanoma research projects and clinical trials,” she said.
“I am looking forward to joining the team of brilliant minds at Melanoma Institute Australia,” Mr King said. “Their results orientation and dedication to improving outcomes for melanoma patients is an inspiration. This is a special opportunity for Australia to lead the rest of the world in research”.
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina this October, to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.
We have been buoyed by the wonderful support for our Melanoma March campaign, and our mission to cover Australia in footprints continues into April!
There was a wonderful feeling of community support amongst the melanoma patients, families and friends at the WA Melanoma Community Form.
The Price family has decided to share their story to inspire Australians to support research into new melanoma treatments.
New research has provided evidence in favour of a structured skin surveillance program for high-risk melanoma patients.
Melanoma research saved Bert's life at 101 and now he wants to give back.
A new MIA online risk calculator for clinicians can determine the likelihood of thin melanoma spreading.